Genetic testing was conducted on all 101 patients screened for the presence of pathogenic variants in genes associated with familial hypercholesterolemia (FH), specifically the LDLR, APOB, PCSK9 and LDLRAP1 genes. The gene discussed is LDLR; the disease is familial hyperaldosteronism.